Đang chuẩn bị liên kết để tải về tài liệu:
Feasibility of administering human pancreatic cancer chemotherapy in a spontaneous pancreatic cancer mouse model
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Both modified FOLFIRINOX (mFFX) and gemcitabine/nab-paclitaxel chemotherapy regimens have been shown to improve clinical outcomes in patients with pancreatic cancer, and are often used interchangeably as the standard of care. |